Company Overview of Rose Pharma A/S
Rose Pharma A/S develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. It focuses on the medical applications of gastrointestinal hormones. Rose Pharma A/S was formerly known as Gastrotech Pharma A/S. The company was founded in 2003 and is based in Roskilde, Denmark.
Founded in 2003
45 46 74 02 00
45 39 17 99 00
Key Executives for Rose Pharma A/S
Similar Private Companies By Industry
|A.J. Aamund A/S||Europe|
|Accip Biotech A/S||Europe|
|ARCEDI BIOTECH ApS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Rose Pharma A/S, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.